[
  {
    "ts": null,
    "headline": "CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?",
    "summary": "On CRSP's first-quarter 2025 earnings call, investors will likely focus on the sales numbers of its new gene therapy, Casgevy.",
    "url": "https://finnhub.io/api/news?id=2cd72b7407f7826a87a3836f1ac1f029d89a4fc60d704183a630b3735ae62b6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745596740,
      "headline": "CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?",
      "id": 134094809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "On CRSP's first-quarter 2025 earnings call, investors will likely focus on the sales numbers of its new gene therapy, Casgevy.",
      "url": "https://finnhub.io/api/news?id=2cd72b7407f7826a87a3836f1ac1f029d89a4fc60d704183a630b3735ae62b6e"
    }
  }
]